Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Clinical guidelines for the treatment of depressive disorders IV. Medications and other biological treatments
Autore:
Kennedy, SH; Lam, RW; Cohen, NL; Ravindran, AV;
Indirizzi:
Univ Toronto, Dept Psychiat, Toronto, ON, Canada Univ Toronto Toronto ON Canada ronto, Dept Psychiat, Toronto, ON, Canada Univ British Columbia, Dept Psychiat, Div Mood Disorders, Vancouver, BC V5Z 1M9, Canada Univ British Columbia Vancouver BC Canada V5Z 1M9 ver, BC V5Z 1M9, Canada Univ Ottawa, Dept Psychiat, Ottawa, ON K1N 6N5, Canada Univ Ottawa OttawaON Canada K1N 6N5 Psychiat, Ottawa, ON K1N 6N5, Canada Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1N 6N5, Canada Univ Ottawa Ottawa ON Canada K1N 6N5 Mol Med, Ottawa, ON K1N 6N5, Canada
Titolo Testata:
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
, volume: 46, anno: 2001, supplemento:, S
pagine: 38S - 58S
SICI:
0706-7437(200106)46:<38S:CGFTTO>2.0.ZU;2-Q
Fonte:
ISI
Lingua:
ENG
Soggetto:
SEROTONIN REUPTAKE INHIBITORS; PLACEBO-CONTROLLED TRIAL; SEASONAL AFFECTIVE-DISORDER; RECURRENT BRIEF DEPRESSION; TRANSCRANIAL MAGNETIC STIMULATION; INDUCED SEXUAL DYSFUNCTION; UNIPOLAR MAJOR DEPRESSION; VAGUS NERVE-STIMULATION; LONG-TERM TREATMENT; DOUBLE-BLIND;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Social & Behavioral Sciences
Clinical Medicine
Citazioni:
162
Recensione:
Indirizzi per estratti:
Indirizzo: Kennedy, SH Univ Toronto, Dept Psychiat, 100 Coll St, Toronto, ON, Canada Univ Toronto 100 Coll St Toronto ON Canada oronto, ON, Canada
Citazione:
S.H. Kennedy et al., "Clinical guidelines for the treatment of depressive disorders IV. Medications and other biological treatments", CAN J PSY, 46, 2001, pp. 38S-58S

Abstract

Background: The Canadian Psychiatric Association and the Canadian Network for Mood and Anxiety Treatments partnered to produce clinical guidelines for psychiatrists for the treatment of depressive disorders. Methods: A standard guidelines development process was followed. Relevant literature was identified using a computerized Medline search supplemented by review of bibliographies. Operational criteria was used to rate the quality of scientific evidence, and the line of treatment recommendations included consensus clinical opinion. This section, "Medications and Other Biological Treatments," is 1 of 7 articles that were drafted and reviewed by clinicians. Revised drafts underwent national and international expert peer review. Results: Evidence-based recommendations are presented for 1) choosing an antidepressant, based on efficacy, tolerability and safety, 2) the optimal use of antidepressants, including augmentation, combination, and switching strategies; 3) maintenance treatment, and 4) electroconvulsive therapy (ECT), light therapy, and additional somatic treatments. Evidence from metaanalyses is presented first, followed by conclusions from randomized controlled trials (RCTs) and if appropriate, open-label data. Conclusions: There is significant evidence to support the role of selective serotonin reuptake inhibitors (SSRIs), novel agents, and classic agents in the treatment of major depressive disorders (MDD). There is also evidenceto support the use of somatic treatments, including ECT and light therapy for some patients with MDD. There is limited evidence for the use of specific medications to treat subtypes of MDD. There is emerging evidence to support augmentation and combination strategies for patients previously nonresponsive to medication.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/01/20 alle ore 18:40:41